ValiRx Plc’s Buy Rating Reaffirmed at Daniel Stewart & Co (VAL)
ValiRx Plc (LON:VAL)‘s stock had its “buy” rating reiterated by equities researchers at Daniel Stewart & Co in a research report issued on Thursday, Analyst Ratings Network.com reports. They currently have a GBX 0.83 ($0.01) price objective on the stock. Daniel Stewart & Co’s price objective would indicate a potential upside of 144.84% from the stock’s previous close.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.